Clinical Trials Development Core for cancer patients
Official title: Clinical Trials Development Core
Funded at Ecog-Acrin Medical Research Foundation · NIH-11289827 · Data updated 2026-11-12
A nationwide cancer research program helps develop new treatments and imaging tools to improve care for adults with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 29, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $3,688,893 |
| NIH project number | 2U10CA180820-12 |
| Project ID | NIH-11289827 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with cancer who may participate in biomarker-driven trials or benefit from advances in imaging-guided therapies.
✕Less likely to help
Patients not eligible for or not benefiting from specific biomarker-guided trials may not see direct benefit.
What this research studies
This grant supports a core that integrates biology, imaging, and clinical trials to bring targeted cancer therapies to a broad group of patients. It coordinates biorepositories, image databases, and translational science to connect cancer biology with treatment effects. The aim is to accelerate scientifically-driven clinical trials that reflect real-world patient care in both large centers and community settings. The work is centered on improving how we understand biomarkers and tailor therapies for adults with cancer.
Why it matters
Potential benefit: If successful, patients could receive faster access to more precisely targeted cancer therapies informed by biology and imaging.
How similar studies have gone: Previous work in biomarker-driven, imaging-guided cancer trials has shown improved trial efficiency and translational insights.
Where this research is happening
-
Ecog-Acrin Medical Research Foundation
Philadelphia, United States Active
Researchers
- Principal investigator: Odwyer, Peter J — Ecog-Acrin Medical Research Foundation
- Study coordinator: Odwyer, Peter J
Related research
Other NIH-funded projects on the same topics.
-
ECOG-ACRIN NCORP Research Base overview for cancer care and prevention
A national cancer research network is running patient-centered trials and biomarker work through community sites to improve prevention, early detection, treatment, and survivorship.
-
Biorepository for Cancer Biospecimens to Advance Cancer Care
A national cancer biorepository program will securely collect, store, and share labeled tissue, blood, and other biospecimens from cancer patients to help researchers develop better tests and treatments.
-
ECOG-ACRIN cancer clinical trials network
This program runs cancer clinical trials and prevention studies to expand treatment options and improve quality of life for people with cancer and cancer survivors.
-
Support Toolkit to Boost Cancer Clinical Trial Participation
A multi-level program to help more cancer patients join NCI-supported clinical trials using a patient-friendly literacy tool and navigators.
-
ECOG-ACRIN Community Cancer Research Network
This program runs clinical trials and prevention projects to improve cancer care and quality of life for people treated in community clinics.
-
Member Site Core (cancer trials network core for biomarker-driven research)
A nationwide cancer trial network core is advancing biomarker-guided therapies by linking imaging, biology, and clinical trials to improve care for adults with cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.